Pharmaceutical Industry Benefits

December 2010
Pharmaceutical Representative;Dec2010, Vol. 40 Issue 12, p26
The article offers a brief overview of the healthcare benefits from pharmaceutical industry in the U.S. It notes that the number of people living with less illness and pain increases as the average life expectancy increases. Pharmaceutical products are considered significant in improving healthcare system through cost effective treatment methods. It points out that cancer drugs and treatments increased the life expectancy for cancer patients by three years since 1980.


Related Articles

  • Rx Makers Target Cancer Focus.  // Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p50 

    The article reports on the progress by pharmaceutical manufacturers and other health care companies in developing therapies to treat cancer which affects 10 million Americans and the second-leading cause of death in the U.S.

  • Navigating Cancer Treatment. Ullman, Kurt // JNCI: Journal of the National Cancer Institute;Feb2014, Vol. 106 Issue 2, p2 

    This article focuses on the popularity of cancer patient navigators in the U.S. Navigators provide additional support and guidance to patients from their initial screening through their diagnostic evaluation, treatment and on to survivorship. The main focus of a patient navigation is the...

  • The Scope Of The Problem.  // Health Affairs;Jan/Feb2009, Vol. 28 Issue 1, p14 

    The article discusses the treatment of the patients with chronic illness and their condition in the U.S. It says that U.S. life expectancy hit a new high as deaths from circulatory diseases and cancer continued to drift downward. Under the medical development, advances in diagnosing and treating...

  • Top pharmacy challenges of 2017. EDLIN, MARI // Managed Healthcare Executive;Jan2017, Vol. 27 Issue 1, p23 

    The article presents the top challenges associated with the U.S. pharmaceutical industry in 2017. Among these challenges are the missing link between medical cost and outcomes, competition, insufficient collaboration in the industry, and the crippling federal policies related to medical care and...

  • Pharma's role in cost control. FLAUM, SANDER A. // Medical Marketing & Media;Sep2014, Vol. 49 Issue 9, p58 

    The article offers the author's insights on the role of pharmaceuticals companies in controling the costs of medicine in the U.S. Topics discussed by the author include the negative reaction of top medical brands to generic competition like Advair Diskus from Glaxo SmithKline (GSK), price...

  • Drug stores emerging as solutions to healthcare crisis. Frederick, Jim // Drug Store News;4/20/2009, Vol. 31 Issue 5, p22 

    The article reports on the emergence of drug stores in the middle of healthcare solutions crisis in 2009 in the U.S. Lower-cost solutions were prompted by increasing traditional model of health care and demand for more cost-effective health intervention. Since drug stores are emerging, the need...

  • But, 50-year-old Americans could lower the bill $1.1 trillion by 2050.  // Research Review (International Council on Active Aging);8/10/2011, Vol. 11 Issue 28, p3 

    The article discusses a study on why life expectancy in the U.S. has dramatically changed since 1975 compared to several European nations. Smoking, obesity and other chronic conditions have been found to negatively affect the longevity of Americans. It further states that better health...

  • fast STATS.  // Healthcare Purchasing News;Dec2006, Vol. 30 Issue 12, p6 

    The article presents statistics on issues related to healthcare purchasing in the U.S., including the expected time an American found to have the virus that causes AIDS can expect to live, the average annual cost of care for a person infected with HIV, the 1993 estimate of life expectancy for a...

  • Comparing cancer care costs by practice type in the US.  // PharmacoEconomics & Outcomes News;Jun2014, Vol. 705 Issue 1, p5 

    The article reports on a 2014 finding in the U.S. that cancer care health costs are significantly lower for patients treated at physician offices than those treated in hospital outpatient settings.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics